Compare Neurocrine Biosciences Inc (NBIX) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Qurate Retail Inc Series A — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Qurate Retail Inc Series A trades at $0.05 (market cap $698.27K). The key difference: Neurocrine Biosciences Inc is far larger — about 24918.7× Qurate Retail Inc Series A's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| NBIX | QVCAQ | |
|---|---|---|
Market Cap | $17.40B | $698.27K |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $15.03 |
52-Week Low | $123.10 | $0.05 |
Enterprise Value | $16.49B | $4.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
